TherapeuticsMD, Inc. (TXMD)
1.75
-0.09
(-4.89%)
USD |
NASDAQ |
Dec 12, 16:00
1.76
+0.01
(+0.57%)
After-Hours: 20:00
TherapeuticsMD Profit Margin (Quarterly): 6.38% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 33.55% |
| Eli Lilly & Co. | 31.72% |
| Pfizer Inc. | 21.32% |
| AbbVie, Inc. | 1.13% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.27% |
| Return on Assets | 0.19% |
| Return on Invested Capital | 0.21% |
| Gross Profit Margin (Quarterly) | 87.76% |
| Operating Margin (Quarterly) | -105.9% |
| Return on Net Operating Assets | 0.71% |